T2 Biosystems (TTOO)
(Real Time Quote from BATS)
$2.40 USD
+0.01 (0.42%)
Updated Sep 13, 2024 10:20 AM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
T2 Biosystems, Inc. [TTOO]
Reports for Purchase
Showing records 1 - 20 ( 28 total )
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
3Q19 Financial Results Reported; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
T2Resistance Panel Ready for Research Use in 3Q19; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
BARDA Contract Awarded; Term Loan Amended; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
T2Bacteria Granted New Technology Add-on Payment; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
2Q19 Results Reported; 2019 Guidance Materially Weakened; Downgrade to Neutral without PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
New Data Demonstrate Utility in Clinics and Biodefense; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
Cost-Effectiveness of Incorporating T2 Panels in Sepsis Diagnosis Published; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
Management Affirms 2019 Revenue Guidance; Reiterate Buy; Adjust Price Target to $10
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
Clinical Performance of T2Bacteria Published; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
1Q19 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
2018 Financial Results Reported; Reiterate Buy; Reducing Price Target to $11
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
T2Resistance Panel Granted Breakthrough Device Designation; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
3Q18 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
T2Bacteria and T2Candida Highlighted at IDWeek 2018; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
T2Lyme More Accurate Than Current Diagnostics in Preliminary Clinical Study; Pivotal Trial Data in 2019; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
2Q18 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
T2Bacteria Clinical Data Presented at ASM Microbe 2018; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R